Menopause Review
facebook
eISSN: 2299-0038
ISSN: 1643-8876
Menopause Review/Przegląd Menopauzalny
Current issue Archive Online First About the journal Editorial board Abstracting and indexing Subscription Contact Ethical standards and procedures Special Issues Instructions for authors Publication charge
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank


3/2010
vol. 9
 
Share:
Share:
abstract:
Review paper

What’s new in the treatment of female pelvic inflammatory disease?

Grzegorz Stachowiak
,
Tomasz Pertyński

Przegląd Menopauzalny 2010; 3: 140–144
Online publish date: 2010/06/16
View full text Get citation
 
Pelvic inflammatory disease (PID) is a large group of inflammatory polymicrobial illnesses of female genital organs, mostly caused by Chlamydia trachomatis and Neisseria gonorrhoeae. When poorly treated it leads to
some serious distant side effects e.g. impaired fertility. Quinolones play an important role in the treatment of PID, whereas newly introduced moxifloxacin is characterized by high therapeutic efficacy and safety.
keywords:

PID, Chlamydia, inflammation, pelvis minor, moxifloxacin


Quick links
© 2026 Termedia Sp. z o.o.
Developed by Termedia.